Titre : | Drug Testing and Analysis, Vol.5, n°1 - January 2013 - Cannabinoids. Part I: Legal policies and physiological effects |
Auteurs : | J. KERWIN, Éditeur scientifique |
Type de document : | Bulletin : Périodique |
Paru le : | 01/01/2013 |
Année de publication : | 2013 |
Langues: | Anglais |
Note de contenu : |
CONTENTS:
• Annual banned-substance review: analytical approaches in human sports drug testing. Thevis M., Kuuranne T., Geyer H., Schänzer W., p. 1-19. • Cannabinoids Part I - Legal policies and physiological effects [Editorial]. Kerwin J., p. 20-21. • Using dopamine research to generate rational cannabinoid drug policy. Loewinger G.C., Oleson E.B., Cheer J.F., p. 22-26. • Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization. Psychoyos D., Vinod K.Y., p. 27-45. • Medical use of cannabis. Cannabidiol: A new light for schizophrenia? Deiana S., p. 46-51. • Cannabis and psychomotor performance: A rational review of the evidence and implications for public policy. Armentano P., p. 52-56. • Considering gender in cannabinoid research: A step towards personalized treatment of marijuana addicts. Fattore L., p. 57-61. • Is today's marijuana more potent simply because it's fresher? Sevigny E.L., p. 62-67. |
Lien : | http://onlinelibrary.wiley.com/doi/10.1002/dta.v5.1/issuetoc |
Dépouillements
Ajouter le résultat dans votre panierArticle : Périodique
The average potency of illicit marijuana in the USA has increased substantially over the past four decades, and observers have suggested a number of likely reasons for this. One set of hypotheses points to a market that has evolved from foreign [...]
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil